Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma Multiforme”

2,105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,105 results

Early research (Phase 1)Not Yet RecruitingNCT04903795
What this trial is testing

BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Who this might be right for
Newly Diagnosed GlioblastomaRecurrent Glioblastoma
Mustafa Khasraw, MBChB, MD, FRCP, FRACP 18
Testing effectiveness (Phase 2)Study completedNCT00028795
What this trial is testing

Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Oncology Group 170
Early research (Phase 1)UnknownNCT03231501
What this trial is testing

HMPL-813 in Treating Patients With Glioblastoma

Who this might be right for
Glioblastoma
Hutchison Medipharma Limited 29
Very early researchLooking for participantsNCT05773326
What this trial is testing

Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

Who this might be right for
High Grade GliomaGliomaGlioma, Malignant+1 more
Nader Sanai 12
Not applicableEnded earlyNCT01954576
What this trial is testing

NovoTTF Therapy in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
GlioblastomaBrain Neoplasms
University of Florida 21
Testing effectiveness (Phase 2)Study completedNCT00501891
What this trial is testing

Bevacizumab in Combination With Metronomic Temozolomide for Recurrent Malignant Glioma

Who this might be right for
Glioblastoma Multiforme
Duke University 32
Early research (Phase 1)Study completedNCT01729260
What this trial is testing

Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide

Who this might be right for
Newly Diagnosed High-Grade Glioma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24
Testing effectiveness (Phase 2)Study completedNCT00012038
What this trial is testing

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)WithdrawnNCT05218408
What this trial is testing

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Who this might be right for
Astrocytoma, Grade IVGlioblastomaGiant Cell Glioblastoma+1 more
Celularity Incorporated
Early research (Phase 1)WithdrawnNCT05341947
What this trial is testing

Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Jeremy Rudnick, M.D
Testing effectiveness (Phase 2)Study completedNCT00006268
What this trial is testing

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Not applicableUnknownNCT03409549
What this trial is testing

Multi-parametric MRI/Fluorine-18 Fluciclovine PET-CT in Glioblastoma

Who this might be right for
Tumor, Brain
The Leeds Teaching Hospitals NHS Trust 12
Not applicableUnknownNCT01637753
What this trial is testing

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Recurrent Malignant Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+1 more
Shandong Lanjin Pharmaceuticals Co.,Ltd 212
Early research (Phase 1)Study completedNCT01294735
What this trial is testing

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Who this might be right for
Recurrence of Solid TumorGlioblastoma MultiformeMelanoma
Merck Sharp & Dohme LLC 19
Early research (Phase 1)Study completedNCT00019071
What this trial is testing

Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01180816
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (Temodar) For Treatment Of Newly Diagnosed GBM And AA

Who this might be right for
Glioblastoma MultiformeAnaplastic Astrocytoma
Northwell Health 21
Testing effectiveness (Phase 2)Ended earlyNCT01836549
What this trial is testing

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAstrocytoma, Grade II+6 more
Pediatric Brain Tumor Consortium 43
Not applicableLooking for participantsNCT05565326
What this trial is testing

Response Assessment During MR-guided Radiation Therapy for Glioblastoma

Who this might be right for
Glioblastoma Multiforme
University of Zurich 20
Testing effectiveness (Phase 2)Study completedNCT00525525
What this trial is testing

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma

Who this might be right for
GlioblastomaGliosarcoma
University of California, San Francisco 74
Very early researchUnknownNCT03347097
What this trial is testing

Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Huashan Hospital 40
Load More Results